Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | STAT3 | P40763 | 3/20 | 0.46 |
| ▸ | IP6K1 | Q92551 | 4/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.42 |
| ▸ | SYK | P43405 | 2/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.41 |
| ▸ | XDH | P47989 | 1/20 | 0.40 |
| ▸ | MGMT | P16455 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.40 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8764949 | 0.86 | POLA1 (0.48) | MAPTSTAT3CDK1MGMTKDR | |
| SCHEMBL8764928 | 0.80 | CDK8 (0.37) | MAPT | |
| SCHEMBL31506448 | 0.77 | GDA (0.55) | MAPTSTAT3SYKXDHKDR | |
| SCHEMBL750335 | 0.77 | GDA (0.55) | MAPTSTAT3SYKXDHKDR | |
| SCHEMBL3072990 | 0.75 | GDA (0.67) | XDH | |
| SCHEMBL1358803 | 0.74 | SYK (0.46) | MAPTSTAT3SYKCDK1XDH | |
| SCHEMBL8718988 | 0.73 | SYK (0.46) | MAPTSTAT3SYKCDK1XDH | |
| SCHEMBL8660442 | 0.72 | EGFR (0.47) | MAPTSTAT3HDAC1HDAC2SYK | |
| SCHEMBL5694112 | 0.70 | NPC1 (0.49) | MAPTADORA3 | |
| SCHEMBL8121393 | 0.69 | STAT3 (0.69) | STAT3IP6K1HDAC1HDAC2CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0461407-B1 | Improved process for the preparation of 2-amino(2,3,5-tri-O-benzyl-beta-D-arabinofuranosyl)adenine | ASH STEVENS INC (US) | 1997-07-30 | — | — | EP | disclosed |
| EP-0456817-B1 | PROCESS FOR THE PREPARATION OF 2-AMINO-9-(2,3,5-TRI-0-BENZYL-BETA-D-ARABINOFURANOSYL)ADENINE AND NOVEL INTERMEDIATES | ASH STEVENS INC (US) | 1996-01-31 | — | — | EP | disclosed |
| US-5206351-A | PROCESS FOR THE PREPARATION OF 2-AMINO (2,3,5-TRI-O-BENZYL-BETA-D-ARABINOFURANOSYL)ADENINE | ASH STEVENS, INC. (US) | 1993-04-27 | — | — | US | disclosed |
| US-5110919-A | Economical preparation of nucleosides | ASH STEVENS, INC. (US) | 1992-05-05 | — | — | US | disclosed |
| EP-0456817-A4 | PROCESS FOR THE PREPARATION OF 2-AMINO-9-(2,3,5-TRI-0-BENZYL-BETA-D-ARABINOFURANOSYL)ADENINE AND NOVEL INTERMEDIATES | — | 1992-04-22 | — | — | EP | disclosed |
| EP-0461407-A1 | Improved process for the preparation of 2-amino(2,3,5-tri-O-benzyl-beta-D-arabinofuranosyl)adenine | ASH STEVENS, INC. (US) | 1991-12-18 | — | — | EP | disclosed |
| EP-0456817-A1 | PROCESS FOR THE PREPARATION OF 2-AMINO-9-(2,3,5-TRI-0-BENZYL-BETA-D-ARABINOFURANOSYL)ADENINE AND NOVEL INTERMEDIATES. | ASH STEVENS INC (US) | 1991-11-21 | — | — | EP | disclosed |
| WO-1991008215-A1 | PROCESS FOR THE PREPARATION OF 2-AMINO-9-(2,3,5-TRI-0-BENZYL-BETA-D-ARABINOFURANOSYL)ADENINE AND NOVEL INTERMEDIATES | ASH STEVENS, INC. (US) | 1991-06-13 | — | — | WO | disclosed |